Celon Pharma S.A. Inventory

The latest inventory for CLN.WA is $24M as of June 2026. That compares with $27M in the prior-year period — down 11.8% year over year. Investors often review this figure alongside Celon Pharma S.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CLN.WA's inventory moved from $27M to $24M — a 11.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Celon Pharma S.A.'s operating scale or balance-sheet position.

A inventory figure of $24M for CLN.WA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CLN.WA's inventory ($24M), review year-over-year change from $27M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.